Determination of γ-aminobutyric acid in human cerebrospinal fluid by isocratic high-performance liquid chromatography

Journal of Chromatography B: Biomedical Sciences and Applications
1990.0

Abstract

It is well known that γ-aminobutyric acid (GABA) is an important inhibitory neurotransmitter in the mammalian nervous system. GABA levels in cerebrospinal fluid (CSF) are considered to be an indicator of GABAergic neuronal functions in the central nervous system. A decrease of the GABA level in CSF has been reported in several neurological disorders, as assayed by ionexchange-fluorimetric and radioreceptor assay methods. Automatic amino acid analysers have been used to investigate whether the amounts of amino acids in human CSF are altered in neurological and mental diseases. Owing to the low concentration of GABA in CSF, however, the increases of aspartic acid and glutamic acid, excitatory neurotransmitters, in the CSF from epileptic patients were reported. In recent years, the fluorogenic reactions of amino acids with o-phthalaldehyde (OPA) and thiol have been exploited in reversed-phase high-performance liquid chromatography (HPLC). Several HPLC systems have been used to measure concentrations of amino acids in CSF. However, the concentration of GABA in CSF was reported in only some papers, because it is less than 10% of that of the other amino acids in CSF. This paper describes a rapid isocratic HPLC method with fluorimetric detection for the determination of the OPA derivative of GABA in human CSF.

Knowledge Graph

Similar Paper

Determination of γ-aminobutyric acid in human cerebrospinal fluid by isocratic high-performance liquid chromatography
Journal of Chromatography B: Biomedical Sciences and Applications 1990.0
Presence and Measurement of Imidazoleacetic Acid, a γ‐Aminobutyric Acid Agonist, in Rat Brain and Human Cerebrospinal Fluid
Journal of Neurochemistry 1989.0
γ‐Glutamylglutamine and Taurine Concentrations Are Decreased in the Cerebrospinal Fluid of Drug‐Naive Patients with Schizophrenic Disorders
Journal of Neurochemistry 1995.0
Measurement of phenylacetic acid in cerebrospinal fluid and plasma using combined gas chromatography/electron capture chemical ionization mass spectrometry
Biological Mass Spectrometry 1988.0
A new method for the determination of l-DOPA and 3-O-methyldopa in plasma and cerebrospinal fluid using gas chromatography and electron capture negative ion mass spectrometry
Clinica Chimica Acta 1988.0
Application of solid phase extraction and high-performance liquid chromatography to qualitative and quantitative analysis of nucleotides and nucleosides in human cerebrospinal fluid
Journal of Chromatography B 2005.0
Amino Acids in Plasma and CSF and Monoamine Metabolites in CSF: Interrelationship in Healthy Subjects
Journal of Neurochemistry 1984.0
Mass fragmentography of 5-hydroxytryptophol and 5-methoxytryptophol in human cerebrospinal fluid
Journal of Chromatography A 1975.0
Agmatine Levels in the Cerebrospinal Fluid of Normal Human Volunteers
Journal of Pain & Palliative Care Pharmacotherapy 2009.0
Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid
Analytical Biochemistry 1985.0